Biotechnology

Abpro Holdings, Inc.

Abpro Holdings, Inc. released FY2024 Q3 earnings on November 14 (EST), actual revenue USD 183K, actual EPS USD -3.2672

Abpro Holdings, Inc. released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -4.5903

Abpro Holdings, Inc. released FY2024 9 Months Earnings on November 14, 2025 (EST), with actual revenue of USD 183K and actual EPS of USD -6.7796

Abpro Holdings, Inc. released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.6339 (forecast USD -1.2)

ABPRO HOLDINGS INC released FY2024 Q2 earnings on August 13, 2025 (EST) with actual revenue of USD 0 and EPS of USD -3.8124

Abpro Holdings, Inc. released FY2025 Semi-Annual Earnings on August 13 (EST) with actual revenue of USD 0 and EPS of USD -3.8004

Abpro Holdings, Inc. released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.5564 (forecast USD -1.2)

Abpro Holdings, Inc. released FY2024 Semi-Annual Earnings on August 13, 2025 (EST) with actual revenue of USD 0 and EPS of USD -2.8201

Abpro Holdings, Inc. released FY2024 Q1 earnings on May 15, 2025 (EST), with actual revenue of USD 0 and EPS of USD 0.3

Abpro Holdings, Inc. released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -2.3999 (forecast USD -1.2)

Abpro Holdings, Inc. released FY2024 Q4 earnings on April 15, 2025 (EST) with actual revenue of USD 0 and EPS of USD -6.1913

Abpro Holdings, Inc. released FY2023 Q4 earnings on April 15 (EST), actual revenue USD 47K, actual EPS USD -2.3633

Abpro Holdings, Inc. released FY2023 earnings on April 15, 2025 (EST) with actual revenue of USD 122 K and EPS of USD -18.3544

Abpro Holdings, Inc. released FY2024 annual earnings on April 15 (EST), actual revenue USD 183K, actual EPS USD -22.3097

Artelo Biosciences

System1

Next Tech

Iczoom

Globavend

Agape ATP

Argan

Corvex

Mangoceuticals

IB ACQUISITION CORP. COM USD0.0001(S/R 28/09/26)

Kiniksa Pharmaceuticals

MiMedx

Rigel Pharma

CapForce Inc.

OpGen

Vertex Pharma

Alnylam Pharma

Argenx

Beigene

Natera

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Abpro Holdings, Inc.(ABPO.US)

Abpro Holdings, Inc. Stock Performance Chart